Literature DB >> 30007747

A new mutation of the SCGA gene is the cause of a late onset mild phenotype limb girdle muscular dystrophy type 2D with axial involvement.

Lidia Gonzalez-Quereda1, Eduard Gallardo2, Ana Töpf3, Alicia Alonso-Jimenez4, Volker Straub3, Maria Jose Rodriguez5, Cinta Lleixa4, Isabel Illa2, Pia Gallano6, Jordi Diaz-Manera7.   

Abstract

Mutations in the SGCA gene cause limb girdle muscular dystrophy type 2D (LGMD2D). We report a family with three affected siblings with a mild phenotype consisting of late onset glutei and axial muscle weakness produced by a new mutation in the SGCA gene leading to a partial expression of the alpha-sarcoglycan protein. The MRI showed muscle atrophy involving paraspinal, pelvic and thigh muscles and a dystrophic pattern was observed in the muscle biopsy. Exome sequencing revealed a homozygous intronic deletion of SGCA and mRNA analysis showed the presence of three different transcripts. The presence, though in a lower proportion, of wild type transcript leads to a milder presentation of the disease. Although clinical symptoms did not entirely correspond with a sarcoglycanopathy, a compatible muscle MRI drove us to look for changes in the sarcoglycan genes. These cases are an example of how clinical, radiological and pathological data enriches the interpretation of exome analysis.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Axial myopathy; NGS; SGCA; Sarcoglycans

Mesh:

Substances:

Year:  2018        PMID: 30007747     DOI: 10.1016/j.nmd.2018.06.002

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  4 in total

1.  First Identification of Rare Exonic and Deep Intronic Splice-Altering Variants in Patients With Beta-Sarcoglycanopathy.

Authors:  Zhiying Xie; Chengyue Sun; Chang Liu; Xujun Chu; Qiang Gang; Meng Yu; Yiming Zheng; Lingchao Meng; Fan Li; Dongliang Xia; Li Wang; Ying Li; Jianwen Deng; He Lv; Zhaoxia Wang; Wei Zhang; Yun Yuan
Journal:  Front Pediatr       Date:  2022-06-22       Impact factor: 3.569

2.  Clinical and genetic spectrum of a large cohort of patients with δ-sarcoglycan muscular dystrophy.

Authors:  Jorge Alonso-Pérez; Lidia González-Quereda; Claudio Bruno; Chiara Panicucci; Afagh Alavi; Shahriar Nafissi; Yalda Nilipour; Edmar Zanoteli; Lucas Michielon de Augusto Isihi; Béla Melegh; Kinga Hadzsiev; Nuria Muelas; Juan J Vílchez; Mario Emilio Dourado; Naz Kadem; Gultekin Kutluk; Muhammad Umair; Muhammad Younus; Elena Pegorano; Luca Bello; Thomas O Crawford; Xavier Suárez-Calvet; Ana Töpf; Michela Guglieri; Chiara Marini-Bettolo; Pia Gallano; Volker Straub; Jordi Díaz-Manera
Journal:  Brain       Date:  2022-04-18       Impact factor: 15.255

Review 3.  Current and Future Approaches to Classify VUSs in LGMD-Related Genes.

Authors:  Chengcheng Li; Gabe Haller; Conrad C Weihl
Journal:  Genes (Basel)       Date:  2022-02-19       Impact factor: 4.096

4.  A 235 Kb deletion at 17q21.33 encompassing the COL1A1, and two additional secondary copy number variants in an infant with type I osteogenesis imperfecta: A rare case report.

Authors:  Numbereye Numbere; David R Weber; George Porter; Mohammed A Iqbal
Journal:  Mol Genet Genomic Med       Date:  2020-04-13       Impact factor: 2.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.